Volume 32, Issue 11 (Februery 2022)
Studies in Medical Sciences 2022, 32(11): 799-814 |
Back to browse issues page
Ethics code: IR.UMSU.REC.1398.261
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jahangiri A, Pashaei M, ghaderi F, vardast M. EVALUATION OF PEG 4000 SOLUTION STABILITY IN DIFFERENT TEMPERATURES AND ENVIRONMENTAL CONDITIONS OVER THE TWELVE MONTHS. Studies in Medical Sciences 2022; 32 (11) :799-814
URL: http://umj.umsu.ac.ir/article-1-5659-en.html
URL: http://umj.umsu.ac.ir/article-1-5659-en.html
Assistant Professor of Pharmaceutics, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author) , jahangiri.az@gmail.com
Abstract: (3202 Views)
Background & Aims: Polyethylene glycol (PEG) solution is used as a laxative for the treatment of constipation in children. Due to the preparation of this solution as a compounding ingredient and solution instability as well as unavailability of the exact expiration date of compounding ingredients, it is necessary and important to investigate the stability of PEG solution.
Materials & Methods: In order to assess the stability of PEG solution, the prepared solutions were stored in various environments (ambient light and temperature, oven, refrigerator and exposed to constant light) for twelve months. Then, they were evaluated for changes in the physical appearance and odor, pH, electrical conductivity, viscosity, refractive index, and microbial contamination over twelve months.
Results: No change in color, turbidity and odor as well as no microbial growth was observed among any of the samples during the study period, which indicates no polymer precipitation and no microbial contamination. Moreover, there was almost no change in FTIR spectra of all samples over the study period. Samples stored in the refrigerator underwent significant changes in pH, refractive index and viscosity after three months, while samples stored in the oven and exposed to light underwent significant changes from the first month.
Conclusion: Considering the destructive effects of light and temperature on PEG solution stability, which can accelerate the aging process, release organic acids and reduce the pH of the solution, the prepared PEG solutions are recommended to be packaged in dark glass containers (due to incompatibility with many plastic containers), stored at a temperature below 25 ° C (preferably in the refrigerator) and finally used up to one month after product preparation.
Materials & Methods: In order to assess the stability of PEG solution, the prepared solutions were stored in various environments (ambient light and temperature, oven, refrigerator and exposed to constant light) for twelve months. Then, they were evaluated for changes in the physical appearance and odor, pH, electrical conductivity, viscosity, refractive index, and microbial contamination over twelve months.
Results: No change in color, turbidity and odor as well as no microbial growth was observed among any of the samples during the study period, which indicates no polymer precipitation and no microbial contamination. Moreover, there was almost no change in FTIR spectra of all samples over the study period. Samples stored in the refrigerator underwent significant changes in pH, refractive index and viscosity after three months, while samples stored in the oven and exposed to light underwent significant changes from the first month.
Conclusion: Considering the destructive effects of light and temperature on PEG solution stability, which can accelerate the aging process, release organic acids and reduce the pH of the solution, the prepared PEG solutions are recommended to be packaged in dark glass containers (due to incompatibility with many plastic containers), stored at a temperature below 25 ° C (preferably in the refrigerator) and finally used up to one month after product preparation.
References
1. Thorat SS, Gupta A. Basic Concept of Stability Profile and Stress Degradation Pathway of Pharmaceutical Formulations: A Review. J Biol Chem Chron 2018;4(3): 34-42. [Google Scholar]
2. Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J Appl Pharm Sci 2012;2(3): 129-38. [Google Scholar]
3. Sengupta P, Chatterjee B, Tekade RK. Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: A comprehensive review. Int J Pharm 2018;543(1-2): 328-44. [DOI:10.1016/j.ijpharm.2018.04.007] [PMID]
4. Carstensen JT, Rhodes CT. Drug stability, revised, and expanded: principles and practices. CRC press; 2000. [DOI:10.1201/b14011]
5. Baertschi SW, Alsante KM, Reed RA. Pharmaceutical stress testing: predicting drug degradation. CRC Press; 2016. [DOI:10.3109/9781439801802]
6. Gremse DA, Hixon J, Crutchfield A. Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediatr 2002;41(4): 225-9. [DOI:10.1177/000992280204100405] [PMID]
7. Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001;139(3): 428-32. [DOI:10.1067/mpd.2001.117002] [PMID]
8. Michail S, Gendy E, Preud'Homme D, Mezoff A. Polyethylene glycol for constipation in children younger than eighteen months old. J Pediatr Gastroenterol Nutr 2004; 39(2): 197-9. [DOI:10.1097/00005176-200408000-00014] [PMID]
9. Dupont C, Leluyer B, Maamri N, Morali A, Joye J-P, Fiorini J-M, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005;41(5): 625-33. [DOI:10.1097/01.mpg.0000181188.01887.78] [PMID]
10. Silva RM, Minim LA, Coimbra JS, Rojas EEG, da Silva LHM, Minim VPR. Density, electrical conductivity, kinematic viscosity, and refractive index of binary mixtures containing poly (ethylene glycol) 4000, lithium sulfate, and water at different temperatures. J Chem Eng Data 2007;52(5): 1567-70. [DOI:10.1021/je060480v]
11. Moreton RC. United States pharmacopeia-national formulary. J Excip Food Chem 2016;6(3): 925. [Google Scholar]
12. Dao H, Lakhani P, Police A, Kallakunta V, Ajjarapu SS, Wu K-W, et al. Microbial stability of pharmaceutical and cosmetic products. Aaps Pharmscitech 2018;19(1): 60-78. [DOI:10.1208/s12249-017-0875-1] [PMID]
13. Darros‐Barbosa R, Balaban MO, Teixeira AA. Temperature and concentration dependence of heat capacity of model aqueous solutions. Int J Food Prop 2003;6(2): 239-58.
https://doi.org/10.1081/JFP-120017845 [DOI:10.1081/JFP-120017815]
14. Santos LC, Poli AL, Cavalheiro C, Neumann MG. The UV/H2O2-photodegradation of poly (ethyleneglycol) and model compounds. J Braz Chem Soc 2009;20: 1467-72. [DOI:10.1590/S0103-50532009000800012]
15. Dash D, Mallika C, Mudali UK. Temperature and Concentration Dependence of Viscosity of Binary Mixtures of PEG-1000+ water. Chem Prod Process 2017;12: 339-46. [DOI:10.1515/cppm-2016-0037]
16. Cox C. Bacterial survival in suspension in polyethylene glycol solutions. Microbiology 1966;45(2): 275-81. [DOI:10.1099/00221287-45-2-275] [PMID]
17. Watson G, Jones N. The biodegradation of polyethylene glycols by sewage bacteria. Water Res 1977;11(1): 95-100. [DOI:10.1016/0043-1354(77)90189-0]
18. Phillips P, Yang Q, Schultz G. Antimicrobial efficacy of negative pressure wound therapy (NPWT) plus instillation of antimicrobial solutions against mature pseudomonas aeruginosa biofilm. Wound Rep Reg 2011;19(5): A42. [URL]
19. Raybaudi-Massilia RM, Mosqueda-Melgar J, Martin-Belloso O. Antimicrobial activity of essential oils on Salmonella enteritidis, Escherichia coli, and Listeria innocua in fruit juices. J Food Prot 2006;69(7): 1579-86. [DOI:10.4315/0362-028X-69.7.1579] [PMID]
20. Wang T, Markham A, Thomas SJ, Wang N, Huang L, Clemens M, et al. Solution Stability of Poloxamer 188 Under Stress Conditions. J Pharm Sci 2019;108(3): 1264-71. [DOI:10.1016/j.xphs.2018.10.057] [PMID]
21. Makeen HA, Pancholi SS, Ali MS, Alam MI, Alam MS, Redaie AM, et al. Shelf life study of extemporaneously prepared omeprazole oral suspension. Saudi J Health Sci 2018;7(1): 28. [Google Scholar]
22. Boscolo O, Perra F, Salvo L, Buontempo F, Lucangioli S. Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients. Hosp Pharm 2019;55(5): 314-22. [DOI:10.1177/0018578719844704] [PMID] [PMCID]
23. Winiarski AP, Infeld MH, Tscherne R, Bachynsky M, Rucki R, Nagano-Mate K. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. J Am Pharm Assoc 2007;47(6): 747-755. [DOI:10.1331/JAPhA.2007.06125] [PMID]
24. Pullagurla SR, Kumar P, Ogun O, Kumru OS, Hamidi A, Hoeksema F, et al. Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability data. Biologicals 2022;75: 21-8. [DOI:10.1016/j.biologicals.2021.12.001] [PMID]
25. Rowe RC, Sheskey P, Quinn M. Handbook of pharmaceutical excipients. Libros Digitales-Pharmaceutical Press; 2009. [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
